Stock APLS APELLIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Apellis Pharmaceuticals, Inc.

Equities

APLS

US03753U1060

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-08 pm EDT 		5-day change 1st Jan Change
42.3 USD -3.64% Intraday chart for Apellis Pharmaceuticals, Inc. -4.28% -29.34%
May. 08 UBS Adjusts Price Target on Apellis Pharmaceuticals to $85 From $89, Maintains Buy Rating MT
May. 08 Wedbush Adjusts Price Target on Apellis Pharmaceuticals to $50 From $57, Maintains Neutral Rating MT

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Global markets live: Tesla, McDonald's, Western Digital, Bed Bath & Beyond, Holcim...Global markets live: Tesla, McDonald's, Western Digital, Bed Bath & Beyond, Holcim... April 03, 2023 at 10:53 am EDT
OPEC ruins the partyOPEC ruins the party April 03, 2023 at 09:24 am EDT
Analyst recommendations: Nvidia, Thermo Fisher Scientific, Danaher, Agilent Technologies, GDS Holdings...ANALYST RECOMMENDATIONS : Nvidia, Thermo Fisher Scientific, Danaher, Agilent Technologies, GDS Holdings... August 25, 2022 at 05:17 am EDT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APLS Stock
  4. News Apellis Pharmaceuticals, Inc.
  5. MarketScreener Editorial Features
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW